MA

Murali Ankireddy Konda

Director Director DIN 10019243
DIN 10019243 First appointment Sep 2022 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Sep 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Murali Ankireddy Konda

Data last updated:

Murali Ankireddy Konda was a Director at V9 Medicare Private Limited (2022) and Designated Partner at Rvm Medical Services Llp (2022–2023). The companies operate in Healthcare.

DIN 10019243
Primary Designation Director
Industry Healthcare
First Appointment 12 Sep 2022

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
V9 Medicare Private Limited U85110TG2022PTC168743
Director29 Nov 20222022₹5.95 Cr (FY 2024)Active
Designated Partner12 Sep 20222022Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
V9 Medicare Private Limited
Rvm Medical Services Llp
Premium access

Shareholding and investment profile for Murali Ankireddy Konda

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Murali Ankireddy Konda

Murali Ankireddy Konda was first appointed on 12 Sep 2022 as Designated Partner at Rvm Medical Services Llp.

Murali Ankireddy Konda held 2 earlier board appointments: V9 Medicare Private Limited (Director, 29 Nov 2022 to 20 Dec 2022); Rvm Medical Services Llp (Designated Partner, 12 Sep 2022 to 09 May 2023).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available